Monashee Investment Management LLC Dynavax Technologies Corp Transaction History

Monashee Investment Management LLC

  • $774 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$4.32 - $11.7 $2.59 Million - $7.03 Million
-600,633 Closed
0 $0
Q2 2020

Aug 11, 2020
BUY
$2.94 - $9.1 $1.77 Million - $5.47 Million
600,633 New
600,633 $5.33 Million
Q4 2017

Feb 09, 2018
SELL
$17.3 - $24.08 $1.51 Million - $2.09 Million
-87,000 Closed
0 $0
Q3 2017

Nov 13, 2017
BUY
$15.2 - $21.5 $1.32 Million - $1.87 Million
87,000
87,000 $1.87 Million

Others Institutions Holding DVAX

# of Institutions
274
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.64B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email